Review of the quality of life and burden of illness in gastroesophageal reflux disease

Digestive Diseases

Volumn 22, Issue 2, 2004, Pages 108-114

  Wiklund, Ingela ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Burden of illness; Gastroesophageal reflux disease; Quality of life, health related

Indexed keywords

ANXIETY; ARTHRITIS; CHRONIC DISEASE; CONGENITAL HEART DISEASE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPHAGIA; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HEADACHE; HEARTBURN; HUMAN; PAIN; PATIENT SATISFACTION; PHYSICIAN; POPULATION RESEARCH; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; REFLUX ESOPHAGITIS; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SLEEP; SYMPTOM; TREATMENT OUTCOME; WORK;

COST OF ILLNESS; GASTROESOPHAGEAL REFLUX; HUMANS; QUALITY OF LIFE;

EID: 4644242302     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080308     Document Type: Review

References (47)

1. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448-1456.
2. Isolauri J, Laippala P: Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995;27:67-70.
3. Dent J, Brun J, Fendrick AM, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ, on behalf of the Genval Workshop Group: An evidence-based appraisal of reflux disease management - The Genval Workshop Report. Gut 1999;44(suppl 2):S1-S16.
4. Peterson WL: Improving the Management of GERD: Evidence-Based Therapeutic Strategies. Bethesda, American Gastroenterological Association, 2002.
5. DeVault KR, Castell DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999;94:1434-1442.
6. Clark CL, Horwitz B: Complications of gastroesophageal reflux disease. Esophagitis, acid laryngitis, and beyond. Postgrad Med 1996; 100:95-97, 100, 106-108 passim.
7. Paterson WG: Extraesophageal manifestations of reflux disease: Myths and reality. Chest Surg Clin North Am 2001;11:523-538.
8. Wiklund I, Talley NJ: Update on health-related quality of life in patients with gastroesophageal reflux disease. Expert Rev Pharmacoeconomics Outcomes Res 2003;3:341-350.
9. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, Lind T, Meyer-Sabellek W, Malfertheiner P, Stolte M, Willich SN: Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - An analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767-776.
10. Madisch A, Kulich KR, Malfertheiner P, Ziegler K, Bayerdorffer E, Miehlke S, Labenz J, Carlsson J, Wiklund IK: Impact of reflux disease on general and disease-related quality of life - Evidence from a recent comparative methodological study in Germany. Z Gastroenterol 2003;41:1137-1143.
11. Kartman B, Gatz G, Johannesson M: Health state utilities in GERD patients with heartburn: A study in Germany and Sweden. Value Health 2001;4:512.
12. Wiklund I: Quality of life in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96:S46-S53.
13. Revicki DA, Wood M, Maton PN, Sorensen S: The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 1998;104:252-258.
14. Stewart AL, Hays RD, Ware JE Jr: The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724-735.
15. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-660.
16. Sjoland H, Wiklund I, Caidahl K, Haglid M, Westberg S, Herlitz J: Improvement in quality of life and exercise capacity after coronary bypass surgery. Arch Intern Med 1996;156:265-271.
17. Trus TL, Laycock WS, Waring JP, Branum GD, Hunter JG: Improvement in quality of life measures after laparoscopic antireflux surgery. Ann Surg 1999;229:331-336.
18. National Heartburn Alliance: Survey 2000 Results: A Community Perspective. www. heartburnalliance.org/survey2000.pdf.
19. Farup C, Kleinman L, Sloan S, Ganoczy D, Chee E, Lee C, Revicki D: The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001;161:45-52.
20. Talley NJ, Junghard O, Wiklund IK: Why do patients with gastroesophageal reflux disease (GERD) have a poor heath-related quality of life (HRQL)? (Abstract). Gastroenterology 2001;120:A423.
21. A Gallup Survey on Heartburn across America. Princeton, Gallup Organization, 1998.
22. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ: Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: The results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 2003;98:1487-1493.
23. Eslick GD, Jones MP, Talley NJ: Non-cardiac chest pain: Prevalence, risk factors, impact and consulting - A population-based study. Aliment Pharmacol Ther 2003;17:1115-1124.
24. Karlson BW, Wiklund I, Bengtson A, Herlitz J: Prognosis, severity of symptoms, and aspects of well-being among patients in whom myocardial infarction was ruled out. Clin Cardiol 1994;17:427-431.
25. Rai A, Orlando R: Gastroesophageal reflux disease. Curr Opin Gastroenterol 1998;14:326-333.
26. Thomson AB, Chiba N, Armstrong D, Tougas G, Hunt RH: The second Canadian gastroesophageal reflux disease consensus: Moving forward to new concepts. Can J Gastroenterol 1998;12:551-556.
27. Thomson ABR, Armstrong D, Barkun AN, Chiba N, Veldhuyzen van Zanten S, White RJ, Escobedo S, Sinclair P, and the CADET-PE Study Group: The high prevalence of clinically significant findings (CSFs) at endoscopy (EDG) in patients with uninvestigated dyspepsia (UD) is not predicted by patients' dyspepsia symptoms (CADET-PE Study) (abstract). Can J Gastroenterol 2002;16:A149.
28. Engels LGJB, Klinkenberg-Knol EC, Dekkers CPM, Beker JA, Tan TG, Timmerman RJ, Haeck PWE: Esomeprazole continues versus on demand maintenance therapy in 1052 gastro-esophageal reflux disease patients: Similar satisfaction but superior quality of life for once daily treatment (abstract). Gut 2003;52:A130.
29. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, Lundell L, Pedersen SA, Carlsson R, Junghard O, Stubberod A, Anker-Hansen O: Quality of life in patients with heartburn but without esophagitis: Effects of treatment with omeprazole. Am J Gastroenterol 1999;94:1782-1789.
30. Allen CJ, Parameswaran K, Belda J, Anvari M: Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus 2000;13:265-270.
31. Tew S, Jamieson GG, Pilowsky I, Myers J: The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis Esophagus 1997;10:9-15.
32. Eloubeidi MA, Provenzale D: Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol 2000;95:1881-1887.
33. Lauritsen K, Junghard O, Eklund S, Wiklund I: The effect of esomeprazole 40 mg on healing, reflux symptoms and quality of life in patients with reflux esophagitis (abstract). Gastroenterology 2002;122:A200.
34. Burton WN, Morrison A, Wertheimer AI: Pharmaceuticals and worker productivity loss: A critical review of the literature. J Occup Environ Med 2003;45:610-21.
35. Dean BB, Crawley JA, Reeves JD, Aguilar D, Sullivan S, Berglund R, Dubois R: The cost of gastroesophageal reflux disease: It's what you don't see that counts. J Managed Care Med 2003;7:6-13.
36. Dean BB, Aguilar D, Crawley JA, Dubois R. Impact of gastroesophageal reflux disease on worker productivity in an employed US population (poster presentation). Dig Dis Week, 2003.
37. Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I: Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD) - Results from a cross-sectional study. Value Health 2002;5:106-113.
38. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ: The burden of illness of gastrooesophageal reflux disease: Impact on work productivity. Aliment Pharmacol Ther 2003;17:1309-1317.
39. Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C: Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease. Arch Intern Med 2000;160:1803-1809.
40. Wiklund I, Hansen A, Bergheim R, Moum B: Esomeprazole is superior to ranitidine 150 mg bid in maintaining quality of life (QoL) in patients with symptomatic GERD. Scand J Gastroenterol 2003;38:22.
41. Crawley JA, Schmitt CM: How satisfied are chronic heartburn sufferers with their prescription medications? Results of the patient unmet needs survey. J Clin Outcomes Manage 2000;7:29-34.
42. Stewart MA: Effective physician-patient communication and health outcomes: A review. CMAJ 1995;152:1423-1433.
43. Coyne KS, Wiklund I, Schmier J, Halling K, Degl' Innocenti A, Revicki D: Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003;18:907-915.
44. Little P, Dorward M, Warner G, Moore M, Stephens K, Senior J, Kendrick T: Randomised controlled trial of effect of leaflets to empower patients in consultations in primary care. BMJ 2004;328:441.
45. Holmes WF, MacGregor EA, Sawyer JP, Lipton RB: Information about migraine disability influences physicians' perceptions of illness severity and treatment needs. Headache 2001;41:343-350.
46. Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M, Thunedborg K: The equivalence of SF-36 summary health scores estimated using standard and countryspecific algorithms in 10 countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1167-1170.
47. Ware JE, Kosinski, M, Gandek, B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M: The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1159-1165.